Peripheral blood progenitor cell transplantation

A single centre experience comparing two mobilisation regimens in 67 patients

P. Mahendra, D. Johnson, M. A. Scott, H. K. Jestice, I. M. Hood, S. Ager, G. Bass, P. Barker, P. A. Boraks, D. M. Bloxham, T. P. Baglin, R. E. Marcus

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Between June 1991 and January 1995 we performed 67 peripheral blood progenitor cell transplants (PBPCT). Ten patients (group 1) were mobilised with 7 gm/m2 of cyclophosphamide followed by daily G-CSF injections (5 μg/kg, subcutaneously). When the white cell count reached 1 x 109/l they were leukapheresed for 5 days. After stem cell infusion they received G-CSF (10 μg/kg/day) until the neutrophil count reached 1.5 x 109/l. Fifty-six patients had PBPCs mobilised with 3 gm/m2 of cyclophosphamide followed by daily subcutaneous G-CSF (5 μg/kg) and PBPCs were harvested on 2 consecutive days, when the white cell count rose to 4 x 109/l. After stem cell infusion this group did not receive G-CSF, In 47 of the 56 patients (group 2) adequate MNC (≥ 4 x 108/kg) and/or CFU-GM (≥ 10 x 104/kg) were obtained. Insufficient MNC and/or CFU-GM were obtained in 10 patients. They were therefore transplanted using a combination of bone marrow and peripheral blood progenitor cells (group 3). Overall 64 patients successfully engrafted. Median days to neutrophils ≥ 0.5 x 109/l were 9 (range 8-13), 12 (range 8-25) and 11 (range 9-16) and to platelets ≥ 50 x 109/l were 11 (range 9-23), 13 (range 9-90) and 16 (range 13-99) in groups 1, 2 and 3 respectively. Patients in group 1 had a faster neutrophil recovery than patients in group 2 (P = 0.0002). The three patients who failed to engraft all received a combination of autologous peripheral blood and bone marrow cells.

Original languageEnglish (US)
Pages (from-to)503-507
Number of pages5
JournalBone Marrow Transplantation
Volume17
Issue number4
StatePublished - Apr 1996

Fingerprint

Cell Transplantation
Blood Cells
Stem Cells
Granulocyte Colony-Stimulating Factor
Granulocyte-Macrophage Progenitor Cells
Neutrophils
Cyclophosphamide
Cell Count
Bone Marrow Cells
Blood Platelets
Bone Marrow
Transplants
Injections

Keywords

  • Mobilisation
  • PBPC transplantation
  • Single centre

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Mahendra, P., Johnson, D., Scott, M. A., Jestice, H. K., Hood, I. M., Ager, S., ... Marcus, R. E. (1996). Peripheral blood progenitor cell transplantation: A single centre experience comparing two mobilisation regimens in 67 patients. Bone Marrow Transplantation, 17(4), 503-507.

Peripheral blood progenitor cell transplantation : A single centre experience comparing two mobilisation regimens in 67 patients. / Mahendra, P.; Johnson, D.; Scott, M. A.; Jestice, H. K.; Hood, I. M.; Ager, S.; Bass, G.; Barker, P.; Boraks, P. A.; Bloxham, D. M.; Baglin, T. P.; Marcus, R. E.

In: Bone Marrow Transplantation, Vol. 17, No. 4, 04.1996, p. 503-507.

Research output: Contribution to journalArticle

Mahendra, P, Johnson, D, Scott, MA, Jestice, HK, Hood, IM, Ager, S, Bass, G, Barker, P, Boraks, PA, Bloxham, DM, Baglin, TP & Marcus, RE 1996, 'Peripheral blood progenitor cell transplantation: A single centre experience comparing two mobilisation regimens in 67 patients', Bone Marrow Transplantation, vol. 17, no. 4, pp. 503-507.
Mahendra, P. ; Johnson, D. ; Scott, M. A. ; Jestice, H. K. ; Hood, I. M. ; Ager, S. ; Bass, G. ; Barker, P. ; Boraks, P. A. ; Bloxham, D. M. ; Baglin, T. P. ; Marcus, R. E. / Peripheral blood progenitor cell transplantation : A single centre experience comparing two mobilisation regimens in 67 patients. In: Bone Marrow Transplantation. 1996 ; Vol. 17, No. 4. pp. 503-507.
@article{93ef7de9a2f9451eaec8cbc59f5b458f,
title = "Peripheral blood progenitor cell transplantation: A single centre experience comparing two mobilisation regimens in 67 patients",
abstract = "Between June 1991 and January 1995 we performed 67 peripheral blood progenitor cell transplants (PBPCT). Ten patients (group 1) were mobilised with 7 gm/m2 of cyclophosphamide followed by daily G-CSF injections (5 μg/kg, subcutaneously). When the white cell count reached 1 x 109/l they were leukapheresed for 5 days. After stem cell infusion they received G-CSF (10 μg/kg/day) until the neutrophil count reached 1.5 x 109/l. Fifty-six patients had PBPCs mobilised with 3 gm/m2 of cyclophosphamide followed by daily subcutaneous G-CSF (5 μg/kg) and PBPCs were harvested on 2 consecutive days, when the white cell count rose to 4 x 109/l. After stem cell infusion this group did not receive G-CSF, In 47 of the 56 patients (group 2) adequate MNC (≥ 4 x 108/kg) and/or CFU-GM (≥ 10 x 104/kg) were obtained. Insufficient MNC and/or CFU-GM were obtained in 10 patients. They were therefore transplanted using a combination of bone marrow and peripheral blood progenitor cells (group 3). Overall 64 patients successfully engrafted. Median days to neutrophils ≥ 0.5 x 109/l were 9 (range 8-13), 12 (range 8-25) and 11 (range 9-16) and to platelets ≥ 50 x 109/l were 11 (range 9-23), 13 (range 9-90) and 16 (range 13-99) in groups 1, 2 and 3 respectively. Patients in group 1 had a faster neutrophil recovery than patients in group 2 (P = 0.0002). The three patients who failed to engraft all received a combination of autologous peripheral blood and bone marrow cells.",
keywords = "Mobilisation, PBPC transplantation, Single centre",
author = "P. Mahendra and D. Johnson and Scott, {M. A.} and Jestice, {H. K.} and Hood, {I. M.} and S. Ager and G. Bass and P. Barker and Boraks, {P. A.} and Bloxham, {D. M.} and Baglin, {T. P.} and Marcus, {R. E.}",
year = "1996",
month = "4",
language = "English (US)",
volume = "17",
pages = "503--507",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Peripheral blood progenitor cell transplantation

T2 - A single centre experience comparing two mobilisation regimens in 67 patients

AU - Mahendra, P.

AU - Johnson, D.

AU - Scott, M. A.

AU - Jestice, H. K.

AU - Hood, I. M.

AU - Ager, S.

AU - Bass, G.

AU - Barker, P.

AU - Boraks, P. A.

AU - Bloxham, D. M.

AU - Baglin, T. P.

AU - Marcus, R. E.

PY - 1996/4

Y1 - 1996/4

N2 - Between June 1991 and January 1995 we performed 67 peripheral blood progenitor cell transplants (PBPCT). Ten patients (group 1) were mobilised with 7 gm/m2 of cyclophosphamide followed by daily G-CSF injections (5 μg/kg, subcutaneously). When the white cell count reached 1 x 109/l they were leukapheresed for 5 days. After stem cell infusion they received G-CSF (10 μg/kg/day) until the neutrophil count reached 1.5 x 109/l. Fifty-six patients had PBPCs mobilised with 3 gm/m2 of cyclophosphamide followed by daily subcutaneous G-CSF (5 μg/kg) and PBPCs were harvested on 2 consecutive days, when the white cell count rose to 4 x 109/l. After stem cell infusion this group did not receive G-CSF, In 47 of the 56 patients (group 2) adequate MNC (≥ 4 x 108/kg) and/or CFU-GM (≥ 10 x 104/kg) were obtained. Insufficient MNC and/or CFU-GM were obtained in 10 patients. They were therefore transplanted using a combination of bone marrow and peripheral blood progenitor cells (group 3). Overall 64 patients successfully engrafted. Median days to neutrophils ≥ 0.5 x 109/l were 9 (range 8-13), 12 (range 8-25) and 11 (range 9-16) and to platelets ≥ 50 x 109/l were 11 (range 9-23), 13 (range 9-90) and 16 (range 13-99) in groups 1, 2 and 3 respectively. Patients in group 1 had a faster neutrophil recovery than patients in group 2 (P = 0.0002). The three patients who failed to engraft all received a combination of autologous peripheral blood and bone marrow cells.

AB - Between June 1991 and January 1995 we performed 67 peripheral blood progenitor cell transplants (PBPCT). Ten patients (group 1) were mobilised with 7 gm/m2 of cyclophosphamide followed by daily G-CSF injections (5 μg/kg, subcutaneously). When the white cell count reached 1 x 109/l they were leukapheresed for 5 days. After stem cell infusion they received G-CSF (10 μg/kg/day) until the neutrophil count reached 1.5 x 109/l. Fifty-six patients had PBPCs mobilised with 3 gm/m2 of cyclophosphamide followed by daily subcutaneous G-CSF (5 μg/kg) and PBPCs were harvested on 2 consecutive days, when the white cell count rose to 4 x 109/l. After stem cell infusion this group did not receive G-CSF, In 47 of the 56 patients (group 2) adequate MNC (≥ 4 x 108/kg) and/or CFU-GM (≥ 10 x 104/kg) were obtained. Insufficient MNC and/or CFU-GM were obtained in 10 patients. They were therefore transplanted using a combination of bone marrow and peripheral blood progenitor cells (group 3). Overall 64 patients successfully engrafted. Median days to neutrophils ≥ 0.5 x 109/l were 9 (range 8-13), 12 (range 8-25) and 11 (range 9-16) and to platelets ≥ 50 x 109/l were 11 (range 9-23), 13 (range 9-90) and 16 (range 13-99) in groups 1, 2 and 3 respectively. Patients in group 1 had a faster neutrophil recovery than patients in group 2 (P = 0.0002). The three patients who failed to engraft all received a combination of autologous peripheral blood and bone marrow cells.

KW - Mobilisation

KW - PBPC transplantation

KW - Single centre

UR - http://www.scopus.com/inward/record.url?scp=15844376081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15844376081&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 503

EP - 507

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 4

ER -